↓ Skip to main content

Current Options and Future Directions in Immune Therapy for Glioblastoma

Overview of attention for article published in Frontiers in oncology, December 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

twitter
42 X users
patent
1 patent

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
85 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Current Options and Future Directions in Immune Therapy for Glioblastoma
Published in
Frontiers in oncology, December 2018
DOI 10.3389/fonc.2018.00578
Pubmed ID
Authors

John Lynes, Victoria Sanchez, Gifty Dominah, Anthony Nwankwo, Edjah Nduom

X Demographics

X Demographics

The data shown below were collected from the profiles of 42 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 85 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 14%
Researcher 11 13%
Student > Master 9 11%
Student > Ph. D. Student 7 8%
Student > Doctoral Student 7 8%
Other 11 13%
Unknown 28 33%
Readers by discipline Count As %
Medicine and Dentistry 15 18%
Biochemistry, Genetics and Molecular Biology 12 14%
Pharmacology, Toxicology and Pharmaceutical Science 5 6%
Agricultural and Biological Sciences 4 5%
Neuroscience 4 5%
Other 15 18%
Unknown 30 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2021.
All research outputs
#1,438,607
of 26,146,017 outputs
Outputs from Frontiers in oncology
#249
of 22,908 outputs
Outputs of similar age
#31,692
of 449,961 outputs
Outputs of similar age from Frontiers in oncology
#4
of 223 outputs
Altmetric has tracked 26,146,017 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,908 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,961 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 223 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.